Given that IBC patients express high levels of E-cadherin and p120, we hypothesized that an imbalance of the pro-growth basolateral cadherin–catenin complexes and tumor-suppressing apical AJs contributes to the pathophysiology of IBC. The gene discussed is CDH1; the disease is inflammatory breast carcinoma.